Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.84 +0.02 (+2.51%)
At close: Sep 11, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Treasury Shares (2020 - 2021)

Rani Therapeutics Holdings (RANI) posted Treasury Shares of $27.6 million for Q2 2021, little changed on a QoQ basis from $27.6 million in Q1 2021, and up 61.72% year-over-year from $17.1 million in Q2 2020.

Analysis

Rani Therapeutics Holdings (RANI) Treasury Shares (2020 - 2021) Analysis & Trends

Rani Therapeutics Holdings has reported Treasury Shares for 2 years, with the latest figure at $27.6 million in Q2 2021.

  • On a quarterly basis, Treasury Shares rose 61.72% year-over-year to $27.6 million in Q2 2021; TTM through Jun 2021 was $27.6 million, a 61.72% increase from a year earlier, with the FY2020 full-year figure at $26.7 million, changed N/A from the prior year.
  • Treasury Shares was $27.6 million for Q2 2021 at Rani Therapeutics Holdings, roughly flat from $27.6 million in the prior quarter.
  • The five-year high for Treasury Shares was $27.6 million in Q1 2021, with the low at $17.1 million in Q2 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Rani Therapeutics Holdings 157.97 Mn 157.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 27.63 Mn
Jun 30, 2021 27.63 Mn
Mar 31, 2021 27.63 Mn
Mar 31, 2021 27.63 Mn
Dec 31, 2020 26.75 Mn
Dec 31, 2020 26.75 Mn
Sep 30, 2020 17.09 Mn
Sep 30, 2020 17.09 Mn
Jun 30, 2020 17.09 Mn
Jun 30, 2020 17.09 Mn